Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.…
Read More »Barclays
Barclays has had a tough few months with tumbling share prices and weak third-quarter results. Now, the British lender is…
Read More »MicroStockHub Barclays takes a neutral view of the U.S. consumer finance sector and initiates coverage of 22 stocks, including consumer…
Read More »Â© Reuters. FILE PHOTO: A branch of Barclays Bank is seen, in London, Britain, February 23, 2022. REUTERS/Peter Nicholls/File Photo…
Read More »Tippapatt/iStock via Getty Images Barclays analyst Ramsey El-Assal upgraded Fidelity National Information Services (NYSE:FIS) to Overweight from Equal Weight on…
Read More »RTX (NYSE:RTX) was downgraded by analysts at both Barclays Capital and RBC Capital Markets after the aerospace and defense company…
Read More »imaginima/iStock via Getty Images “It’s too soon to be bullish” on the U.S. power and utilities sector (NYSEARCA:XLU), but there…
Read More »porcorex Barclays has initiated coverage of Fortrea (NASDAQ:FTRE) with a equal weight rating, stating that it sees the clinical research…
Read More »Dzmitry Dzemidovich While investors are bracing for yet another challenging quarter when earnings season kicks off for commercial-stage biopharma later…
Read More »Oli Scarff Barclays says it has chosen Biomea Fusion (NASDAQ:BMEA), Replimune (NASDAQ:REPL), Syndax Pharmaceuticals (NASDAQ:SNDX) and Iovance Biotherapeutics (NASDAQ:IOVA) as…
Read More »